Medicine & Life Sciences
Dogs
95%
Canidae
53%
Osteosarcoma
26%
Lymphoma
22%
Neoplasms
20%
Doxorubicin
20%
Progression-Free Survival
19%
Drug Therapy
16%
Pets
14%
Lomustine
14%
CHOP protocol
13%
Cats
12%
Transitional Cell Carcinoma
11%
Veterinary Clinical Trials
10%
rabacfosadine
10%
Cyclophosphamide
10%
Regulatory T-Lymphocytes
9%
toceranib phosphate
9%
iniparib
9%
Mast Cells
9%
Therapeutics
9%
Neoplasm Metastasis
9%
Carboplatin
9%
Maximum Tolerated Dose
8%
Survival
8%
Prednisone
8%
Diphenhydramine
7%
NSC 724998
7%
Authorship
7%
Topoisomerase I Inhibitors
7%
Carcinoma
6%
Piroxicam
6%
Chlorambucil
6%
Hemangiosarcoma
6%
T-Cell Lymphoma
6%
Neutropenia
6%
United States Food and Drug Administration
6%
Zoledronic Acid
6%
Cutaneous T-Cell Lymphoma
6%
Amputation
6%
Pharmacokinetics
6%
Investigational Therapies
5%
Melphalan
5%
Osteolysis
5%
Leiomyosarcoma
5%
Microwaves
5%
Non-Hodgkin's Lymphoma
5%
indimitecan
5%
Curcumin
5%
Lymphoma, Large B-Cell, Diffuse
5%
Agriculture & Biology
dogs
100%
neoplasms
44%
osteosarcoma
29%
drug therapy
27%
doxorubicin
26%
lymphoma
25%
T-cell lymphoma
16%
carcinoma
16%
metastasis
14%
B-cell lymphoma
14%
cyclophosphamide
13%
clinical trials
13%
dosage
12%
cats
12%
T-lymphocytes
12%
prednisone
11%
mast cells
11%
protocols
10%
therapeutics
10%
neutropenia
9%
therapy dogs
9%
hemangiosarcoma
9%
maximum tolerated dose
8%
leiomyosarcoma
8%
Golden Retriever
8%
acute kidney injury
7%
positron-emission tomography
7%
pets
7%
urinary tract
7%
prostatic neoplasms
7%
mouth
6%
gonadectomy
6%
melanoma
6%
bone resorption
6%
amputation
6%
lymph nodes
6%
curcumin
6%
computed tomography
6%
arrhythmia
6%
angiogenesis
5%
terminology
5%
sarcoma
5%
adenocarcinoma
5%
ultrasonography
5%
cross-over studies
5%
tongue
5%